Latest News about AZN
Recent news which mentions AZN
From Benzinga
 From Benzinga
 
   Earnings Scheduled For April 29, 2022
   
  
  
  April 29, 2022
  From Benzinga
 
   Pandemic is not over yet, says Dr. Fauci, and WHO says omicron accounted for 99.7% of all cases sequenced in latest week
   
  
  
  April 28, 2022
  From MarketWatch
 From Benzinga
 From Benzinga
 
   Daiichi Sankyo - AstraZeneca's Enhertu Receives Third Breakthrough Therapy Tag In Breast Cancer
   
  
  
  April 27, 2022
  From Benzinga
 From Benzinga
 
   3 Biotech Stocks Under $10 to Add to Your Buy List
   
  
  
  April 26, 2022
  From InvestorPlace
 From MarketWatch
 
   Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall
   
  
  
  April 25, 2022
  From Benzinga
 
   AstraZeneca's Tremelimumab/Imfinzi Combo Regime Goes Under Priority FDA Review For Liver Cancer
   
  
  
  April 25, 2022
  From Benzinga
 From Motley Fool
 
   2 Dividend Stocks to Buy and Hold Forever
   
  
  
  April 22, 2022
  From Motley Fool
 
   World's Largest Vaccine Manufacturer Stops Making COVID-19 Vaccines As 200M Doses Pile-Up: Bloomberg
   
  
  
  April 22, 2022
  From Benzinga
 
   Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
   
  
  
  April 22, 2022
  From Benzinga
 
   2 Charts Big Pharma Investors Need to Understand
   
  
  
  April 21, 2022
  From Motley Fool
 
   If You Invested $100 In AstraZeneca 5 Years Ago, Here's How Much You Would Have Today
   
  April 21, 2022
  Tickers 
   AZN
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   7 Potential Biotech Stocks Buyout Targets in 2022
   
  
  
  April 21, 2022
  From InvestorPlace
 
   AstraZeneca's COVID-19 Antibody Provides Protection For At Least Six Months In High-Risk Individuals
   
  
  
  April 21, 2022
  From Benzinga
 
   4 Undervalued Biotech Stocks to Add to Your Buy List
   
  
  
  April 20, 2022
  From InvestorPlace
 From Benzinga
 From Benzinga
 
   Daiichi Sankyo - AstraZeneca's Enhertu Receives Priority Review In US For Lung Cancer
   
  
  
  April 19, 2022
  From Benzinga
 
   Why Nektar Therapeutics Stock Is Crashing Today
   
  
  
  April 18, 2022
  From Motley Fool
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
